Table 1.
Patient characteristics (n=16,194)
No (%) | |
---|---|
Sex | |
Female | 5,606 (34.62) |
Male | 10,588 (65.38) |
Race/Ethnicity | |
Caucasian | 13,709 (84.65) |
Black | 1,001 (6.18) |
Hispanic | 763 (4.71) |
Other | 721 (4.45) |
Age quartiles | |
<69 | 3,111 (19.21) |
69–74 | 4,674 (28.86) |
74–79 | 3,722 (22.98) |
>79 | 4,687 (28.94) |
Disease sub-site | |
Oral cavity | 6,371 (39.34) |
Larynx | 5,521 (34.09) |
Oropharynx | 1,308 (8.08) |
Nasopharynx | 360 (2.22) |
Missing | 2,634 (16.27) |
SEER stage | |
In situ/Localized | 5,349 (33.03) |
Regional | 5,131 (31.68) |
Distant | 1,372 (8.47) |
Unstaged/Missing | 4,342 (26.81) |
Comorbidity | |
0 | 9,340 (57.68) |
1 | 4,123 (25.46) |
2 | 2,731 (16.86) |
Treatment Modality | |
Surgery alone | 4,147 (25.61) |
Surgery + adjuvant therapy | 4,430 (27.36) |
Radiation alone | 4,130 (25.50) |
Chemoradiation | 3,487 (21.53) |
2-Year Prevalence (95% CI) | |
Dysphagia | 7,335 (45.29) |
Stricture | 1,649 (10.18) |
Pneumonia | 4,252 (26.26) |
Aspiration pneumonia | 1,400 (8.65) |
Total | 16,194 |